PUGNAc treatment leads to an unusual accumulation of free oligosaccharides in CHO cells
- 15 February 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Biochemistry
- Vol. 151 (4) , 439-446
Abstract
Free oligosaccharides (fOS) are generated as the result of N-glycoproteins catabolism that occurs in two distinct principal pathways: the endoplasmic reticulum-associated degradation (ERAD) of misfolded newly synthesized N-glycoproteins and the mature N-glycoproteins turnover pathway. The O-(2-acetamidO-2-deoxy-d-glucopyranosylidene) amino-N-phenylcarbamate (PUGNAc) is a potent inhibitor of the O-GlcNAcase (OGA) catalysing the cleavage of β-O-linked 2-acetamido-2-deoxy-β-d-glucopyranoside (O-GlcNAc) from serine and threonine residues of post-translationaly O-GlcNAc modified proteins. In order to estimate the impact of O-GlcNAc modification on N-glycoproteins catabolism, fOS were analysed by mass spectrometry (MS). MS analysis revealed the appearance of an unusual population of fOS after PUGNAc treatment. The structures representing this population have been identified as containing non-reducing end GlcNAc residues resulting from incomplete lysosomal fOS degradation. Only observed after PUGNAc treatment, the NButGt, another OGA inhibitor, did not lead to the appearance of this population. These abnormal fOS structures have clearly been shown to accumulate in membrane fractions as the consequence of lysosomal β-hexosaminidases inhibition by PUGNAc. As lysosomal storage disorders (LSD) are characterized by the accumulation of storage material as fOS in lysosomes, our study evokes that the use of PUGNAc could mimic a LSD. This study clearly points out another off target effects of PUGNAc that need to be taken into account in the use of this drug.Keywords
This publication has 25 references indexed in Scilit:
- Cross Talk Between O-GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription, and Chronic DiseaseAnnual Review of Biochemistry, 2011
- A Selective Inhibitor Gal‐PUGNAc of Human Lysosomal β‐Hexosaminidases Modulates Levels of the Ganglioside GM2 in Neuroblastoma CellsAngewandte Chemie International Edition, 2009
- Elevation of Global O-GlcNAc Levels in 3T3-L1 Adipocytes by Selective Inhibition of O-GlcNAcase Does Not Induce Insulin ResistanceJournal of Biological Chemistry, 2008
- Phosphoinositide signalling links O-GlcNAc transferase to insulin resistanceNature, 2008
- Man2C1, an α-mannosidase, is involved in the trimming of free oligosaccharides in the cytosolBiochemical Journal, 2006
- Nucleolin: acharan sulfate-binding protein on the surface of cancer cellsGlycobiology, 2004
- Roles of N-Linked Glycans in the Endoplasmic ReticulumAnnual Review of Biochemistry, 2004
- Cytoplasmic peptide: N ‐glycanase (PNGase) in eukaryotic cells: occurrence, primary structure, and potential functionsThe FASEB Journal, 2002
- Catabolism of glycan moieties of lipid intermediates leads to a single Man5GlcNAc oligosaccharide isomer: a study with permeabilized CHO cellsGlycobiology, 1995
- Fate of Oligosaccharide‐Lipid Intermediates Synthesized by Resting Rat‐Spleen LymphocytesEuropean Journal of Biochemistry, 1980